<DOC>
	<DOC>NCT00383422</DOC>
	<brief_summary>The purpose of this study is to compare the effect of arzoxifene to raloxifene on the bone mineral density (bone strength).</brief_summary>
	<brief_title>Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis, Postmenopausal</mesh_term>
	<mesh_term>Raloxifene Hydrochloride</mesh_term>
	<criteria>Must have osteoporosis Must be between 50 and 75 years old and be able to walk Have at least two of your back bones that can be xrayed Have not had a period in at least two years Be willing to have blood tests Have a bone disease other than osteoporosis History of estrogen dependent cancer History of stroke or certain heart problems Possibly have an allergy to raloxifene or arzoxifene Have certain abnormal lab values History of seizure disorder Have unexplained vaginal bleeding or an abnormal pap smear</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>